Juniper Biologics
Scope
Date
~
-
Bio & Pharma
Samsung Biologics bags $183 million CMO order from Pfizer
Samsung Biologics Co., the world’s No. 1 contract drug maker in terms of production capacity, has won a $182.7 million contract manufacturing ...
Mar 02, 2023 (Gmt+09:00)
-
Earnings
Samsung Biologics’ profit near doubles on strong orders
Samsung Biologics Co., the world’s top contract drugmaker, said its profit almost doubled last year thanks to more orders as its sales surged ...
Jan 29, 2023 (Gmt+09:00)
-
Chief Executives
Samsung Biologics CEO focuses on global business
John Rim, chief executive of Samsung BioLogics will directly lead his company's global sales operations for biopharmaceuticals through contract deve...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte to invest more in US bio biz, spend $3 bn in Korea
SAN FRANCISCO -- South Korea’s Lotte Biologics Co. is considering investing more in the US bio industry and spending $3 billion in new factori...
Jan 11, 2023 (Gmt+09:00)
-
Carbon neutrality
Samsung Biologics receives Terra Carta Seal
Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it was awarded the Sustainable Markets Initiative’s Ter...
Jan 11, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Hansol Chemical to enter bio industry with BiOCS acquisition
Hansol Chemical Co., a unit of South Korea’s paper-focused conglomerate Hansol Group, is expanding its business scope to biomaterials by acqui...
Dec 27, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics in CDO deal talks with global pharma firm
FRANKFURT – Samsung Biologics Co., the world’s largest contract drugmaker, is in talks to develop medicines for a global pharmaceutical ...
Nov 07, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea's Samsung Biologics signs $296 mn CMO deal with GSK
South Korea’s Samsung Biologics Co. has signed a $296.1 million deal to supply biopharmaceutical products to UK-based multinational pharma gia...
Oct 21, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics opens the world's largest CDMO factory
South Korea’s Samsung Biologics Co.’s new biopharmaceuticals plant launched operations on Tuesday, a move expected to widen the gap betw...
Oct 11, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics, Samsung C&T extends investment in US biotech firms
The Life Science Fund, jointly launched by Samsung Biologics and Samsung C&T Corp., announced Wednesday it invested $15 million in US biotech fi...
Aug 17, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics to double CDMO capacity with new plants worth $5.3 bn
Samsung Biologics Co., the world’s largest contract drugmaker, plans to double its manufacturing capacity by building four additional plants w...
Jul 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion, Samsung Biologics eye record-high annual sales
South Korea’s two major biopharmaceutical companies, Celltrion Inc. and Samsung Biologics Co., are respectively expecting more than 2 trillion...
Jul 08, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics signs $81 mn CMO deal with Novartis
South Korea’s Samsung Biologics Co. has inked an $81 million contract manufacturing deal with Novartis, the world’s fifth-largest pharma...
Jun 07, 2022 (Gmt+09:00)
language -
Mergers & Acquisitions
Lotte to buy BMS' biologics plant in Syracuse for $160 mn
South Korea's Lotte Group has agreed to buy Bristol Myers Squibb's (BMS) biologics plant in Syracuse in the state of New York for $160 million, the ...
May 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Kolon Life inks technology transfer deal with Juniper Biologics
South Korea’s pharmaceutical company Kolon Life Science Inc. signed a technology export deal worth up to 723.4 billion won ($589.1 million) wi...
Apr 13, 2022 (Gmt+09:00)
-
Rights offerings
Samsung Biologics to raise $2.6 bn in rights issue
Samsung Biologics Co., a global contract development and manufacturing organization (CDMO) and a biotech division under the Samsung Group, is set ...
Apr 12, 2022 (Gmt+09:00)
-
COVID-19
Korea approves export of Samsung Biologics-made Moderna vaccine
South Korea approved exports of Moderna Inc.’s COVID-19 vaccine produced by Samsung Biologics Co. in a move that will help the country’s...
Dec 14, 2021 (Gmt+09:00)
language -
Pharmaceuticals
Samsung Biologics wins another Eli Lilly COVID treatment order
Samsung Biologics Co., a global contract development and manufacturing organization (CDMO), has stepped up its partnerships with global big pharmas ...
Nov 19, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics-made Moderna vaccine available to Koreans this week
Moderna Inc.’s COVID-19 vaccine first produced by Samsung Biologics Co. under a contract manufacturing organization (CMO) service will be avai...
Oct 27, 2021 (Gmt+09:00)
language -
COVID-19
Samsung Biologics gears up to produce mRNA drug substance
South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...
Sep 01, 2021 (Gmt+09:00)
language -
COVID-19
Korean govt to spend $1.9 billion to become world’s leading vaccine maker
The South Korean government will invest 2.2 trillion won ($1.9 billion) by 2025 to become a top five vaccine producer in the world. President Moon J...
Aug 05, 2021 (Gmt+09:00)
-
Biosimilars
Celltrion, Samsung Bioepis anticipate increased biosimilar sales in Europe
South Korean biosimilar companies such as Celltrion Inc. and Samsung Bioepis Co. are likely to see their sales hike by tens of millions of dollars...
Jul 12, 2021 (Gmt+09:00)
-
IPOs
World’s top COVID-19 test kit maker draws $28 bn in IPO subscriptions
The IPO of SD Biosensor Inc., which has sold the most COVID-19 test kits in the world -- selling more than 700 million kits from February 2020 to Ma...
Jul 09, 2021 (Gmt+09:00)
-
COVID-19 vaccines
Samsung Bio plans to manufacture mRNA drug substance from 2022
Samsung Biologics will be entering the drug substance segment of the COVID-19 vaccine contract manufacturing business. According to industry sources...
May 31, 2021 (Gmt+09:00)
language -
COVID-19
Samsung Biologics to make Moderna’s mRNA vaccine from Q3
Samsung Biologics Co. will be manufacturing the US company Moderna’s COVID-19 vaccine (mRNA-1273) from the second half of this year in Korea. ...
May 23, 2021 (Gmt+09:00)
language -
COVID vaccines
Samsung Biologics in talks to produce Pfizer’s COVID-19 vaccine
South Korea’s Samsung Biologics Co. is in talks with Pfizer Inc.to produce the US drugmaker’s COVID-19 vaccine under a contract manufact...
May 12, 2021 (Gmt+09:00)
language -
COVID-19
Samsung Biologics’ focused approach pays off in 2020
Samsung Biologics Co. delivered forecast-beating earnings this week, with its sales topping 1 trillion won ($905 million) for the first time in its ...
Jan 27, 2021 (Gmt+09:00)
-
Mergers & Acquisitions
SK in talks to buy French biologics contract manufacturer
SK Holdings is in the early stages of negotiations to acquire France’s biologic contract manufacturing organization (CMO) Yposkesi, in a move ...
Dec 17, 2020 (Gmt+09:00)
language -
Bio earnings
Samsung Biologics Jan-Sept profit beats entire 2019 gains
Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO) in terms of capacity, posted an operating profit of 200.2 b...
Oct 21, 2020 (Gmt+09:00)
-
Bio
Samsung Biologics to double bioreactor capacity with $1.5 bn new plant
Samsung Biologics Co. Ltd., the world’s largest contract manufacturing organization (CMO) in terms of capacity, will invest 1.74 trillion won ($...
Aug 11, 2020 (Gmt+09:00)
Latest News
- 1 Hyundai, Waymo forge multi-year, strategic partnership for self-driving vehicles
- 2 AI startup MarqVision raises $16.5 mn to close Series A
- 3 Taihan Cable wins $630 mn power grid project in Singapore
- 4 Korean startup scene is gloomy, say 2 out of 5 startup CEOs
- 5 MBK ups stakes for Korea Zinc to match buyback offer